![Published clinical trials in sarcoma and TIM histotypes. The histograms... | Download Scientific Diagram Published clinical trials in sarcoma and TIM histotypes. The histograms... | Download Scientific Diagram](https://www.researchgate.net/publication/349614101/figure/fig1/AS:998403437781002@1615049337778/Published-clinical-trials-in-sarcoma-and-TIM-histotypes-The-histograms-present-the.png)
Published clinical trials in sarcoma and TIM histotypes. The histograms... | Download Scientific Diagram
![GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, H2, 2021" provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, H2, 2021" provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical](https://www.globaldata.com/store/wp-content/uploads/sites/2/2021/09/Ewing-Sarcoma-Clinical-Trials-Market-by-G7-Countries-1024x493.png)
GlobalData's clinical trial report, “Ewing Sarcoma - Global Clinical Trials Review, H2, 2021" provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical
World-first clinical trial targets immune molecule IL23 as potential treatment for sarcoma | Garvan Institute of Medical Research
![NIH clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma | National Institutes of Health (NIH) NIH clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma | National Institutes of Health (NIH)](https://irp.nih.gov/sites/default/files/media/image/2023-02/news-12-28-2022-NIH_clinical_trial_atezolizumab_shrunk.png)
NIH clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma | National Institutes of Health (NIH)
![The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-5163-2/MediaObjects/12885_2018_5163_Fig2_HTML.png)
The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text
![Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets | Nature Communications Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-30453-x/MediaObjects/41467_2022_30453_Fig1_HTML.png)
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets | Nature Communications
![Early Assessment of Masses, Lesions Encouraged by Duke Sarcoma Team | Duke Health Referring Physicians Early Assessment of Masses, Lesions Encouraged by Duke Sarcoma Team | Duke Health Referring Physicians](https://physicians.dukehealth.org/sites/default/files/article/MC-2040%20Images%20for%20CPT%20186%20Orthopaedics.png)
Early Assessment of Masses, Lesions Encouraged by Duke Sarcoma Team | Duke Health Referring Physicians
![Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development - Lee - 2019 - Cancer Medicine - Wiley Online Library Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development - Lee - 2019 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/48c89712-2984-425e-b99c-0c395fb03e27/cam41958-fig-0001-m.jpg)
Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development - Lee - 2019 - Cancer Medicine - Wiley Online Library
![The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-5163-2/MediaObjects/12885_2018_5163_Fig1_HTML.png)
The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text
![Cancers | Free Full-Text | Status of the Current Treatment Options and Potential Future Targets in Uterine Leiomyosarcoma: A Review Cancers | Free Full-Text | Status of the Current Treatment Options and Potential Future Targets in Uterine Leiomyosarcoma: A Review](https://pub.mdpi-res.com/cancers/cancers-14-01180/article_deploy/html/images/cancers-14-01180-g001.png?1645710456)
Cancers | Free Full-Text | Status of the Current Treatment Options and Potential Future Targets in Uterine Leiomyosarcoma: A Review
![Patients with a rare and aggressive form of liposarcoma need treatment advances | Boehringer Ingelheim US Patients with a rare and aggressive form of liposarcoma need treatment advances | Boehringer Ingelheim US](https://www.boehringer-ingelheim.com/us/sites/default/files/2022-11/786212590_bi_sarcoma-alliance_quotegreens.jpg)